PAR-22-132 - Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release Date Expiration Date Activity Code(s)
Notice of NHLBI Participation in PAR-22-132 "Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low-and Middle-Income Countries and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional)" NOT-HL-22-035 NHLBI Jul 5, 2022 Sep 8, 2026 R01
For technical issues E-mail OER Webmaster